Background: We retrospectively identified the prognostic factors in cases of synchronous
Introduction
Surgical resection is now accepted as a viable treatment for colorectal cancer metastases to the liver. The overall 3-and 5-year survival rates after hepatic resection in recent reports have ranged from 44% to 59% and 30% to 40%, respectively. The median survival time in these reports has ranged from 35 to 40 months 1!5 . In most cases the surgery is Our group retrospectively evaluated the prognostic factors in cases of synchronous liver metastases from colorectal cancer and established a clinical strategy for how surgery for the colorectal lesion should be performed and how and when hepatectomy should be performed at our institution. Nine patients underwent a second hepatectomy, 1 patient underwent a third hepatectomy, and resections were ruled out in 14 patients because of gross residual disease within or outside the liver. In these 14 patients, lymph node metastases in the hepatoduodenal ligament were found in 4 patients and direct invasion to the diaphragm was found in 2.
Patients and Methods
All 24 of these patients were excluded from the study. Statistical comparisons between groups were F i g . 1 Ov e r a l l s u r v i v a l i n t h e s y n c h r o n o u s g r o u p ( S g r o u p ) a n d me t a c h r o n o u s g r o u p ( M g r o u p ) . Th e r e we r e n o s i g n i f i c a n t d i f f e r e n c e s i n s u r v i v a l r a t e s b e t we e n t h e s e t wo g r o u p s . ( P = 0 . 3 5 4 2 )
Ta b l e 1 P a t i e n t c h a r a c t e r i s t i c s i n t h e s y n c h r o n o u s a n d me t a c h r o n o u s g r o u p s 
Results

Demographics and Operative Date
The characteristics of the patients in the synchronous and metachronous groups are summarized in Table 1 . There were no significant differences between the groups in terms of patient sex, age, primary tumor site, stage, tumor factor, pathological lymphatic invasion, pathological lymph node metastases, maximum diameter of the liver lesions, intrahepatic distribution, type of operative procedure , or tumor-free margin . Significant differences between the groups were noted in the pathological vascular invasion of the primary tumor and the number of metastatic liver tumors.
Surgical Results
The mean follow-up period was 31 months (median, 19 months; range, 1!134 months). There were no deaths in the first 30 days after surgery.
The overall 1-, 3-, 5-, and 10-year survival rates of the 108 patients were 85.5%, 51.4%, 41.6%, and 30.9%, respectively. The overall 1-, 3-, and 5-year survival rates were 49.5%, 39.0%, and 26.7% in the synchronous group and 58.1%, 49.1% and 39.2% those in the metachronous group (Fig. 1 ). There were no significant differences between the overall survival Ta b l e 2 Un i v a r i a t e a n a l y s i s o f p r o g n o s t i c f a c t o r s i n a l l c a s e s 9 5 %CI R e l a t i v e r i s k P v a l u e 0 . 5 9 3～ 1 . 8 1 6 1 . 0 3 8 0 . 8 Ty p e o f r e s e c t i o n ( a n a t o mi c : n o n -a n a t o mi c ) 2 . 5 1 3～ 1 2 . 5 0 7 5 . 6 0 6 0 . 0 0 0 1 Tu mo r -f r e e ma r g i n ( > _ 5 mm : < 5 mm) rates of the two groups. Table   2 ).
Analysis of Prognostic Factors in All Cases
Analysis of Prognostic Factors in Cases of
Synchronous Metastasis
Univariate analysis of the 13 factors considered to be possible prognostic factors in the synchronous group alone revealed significant differences in
F i g . 2 Ov e r a l l s u r v i v a l i n t h e s y n c h r o n o u s h e p a t e c t o my g r o u p ( S H g r o u p ) a n d me t a c h r o n o u s h e p a t e c t o my g r o u p ( MH g r o u p ) . He p a t i c l e s i o n s a n d p r i ma r y l e s i o n s
we r e d i a g n o s e d s i mu l t a n e o u s l y i n 4 4 p a t i e n t s . Th e r e we r e n o s i g n i f i c a n t d i f f e r e n c e s i n s u r v i v a l r a t e s b e t we e n t h e s e t wo g r o u p s . ( P = 0 . 6 6 3 1 )
Ta b l e 4 Mu l t i v a r i a t e a n a l y s i s o f p r o g n o s t i c f a c t o r s i n t h e s y n c h r o n o u s g r o u p ( S g r o u p )
9 5 %CI R e l a t i v e r i s k P v a l u e 0 . 4 The number of liver tumors was not significant, with a P value of around 0.10 ( Table 3) . Tumor-free margin was the only significant prognostic factor in a multivariate analysis of the stratified group ( Table 4) .
Survival Rates of Patients with Hepatic and Primary Lesions Detected Simultaneously
Of the 45 patients with hepatic and primary lesions detected simultaneously, 37 underwent synchronous hepatectomy (SH group) and 8 underwent metachronous hepatectomy (MH group).
The overall 1-, 3-, and 5-year survival rates were 81.8%, 37.8%, and 37.8% in the SH group and 71.4%, 57.1%, and 57.1% in the MH group, respectively (Fig.   2) . No significant differences in overall survival were found between these two groups. Some groups have identified a tumor-free margin of less than 1 cm as a significant prognostic factor 1, 2, 8, 19 . Others have deemed the safety margin adequate when no part of the lesion is exposed on the cut surface of the resection 4, 5, 13, 14 . In our study, a tumor-free margin of less than 5 mm significantly affected the prognosis. This 5-mm tumor-free margin is achieved when no lesion is exposed on the cut surface or comes into contact with a main branch.
The value of the tumor-free margin as a prognostic factor is compromised when satellite nodules remain in the remnant liver. Some studies have found a positive correlation between the maximum diameter of the main tumor and the frequency of satellite nodules 19!21 . In others studies, the appearance of satellite nodules around the main metastatic lesion is rare 13, 14 . In any case, the relationship between satellite nodules and tumor recurrence in the remnant liver remains controversial.
A tumor-free margin in hepatectomy was the only significant predictor of a favorable prognosis in the synchronous group in our multivariate analysis.
Under this criterion, the tumor-free margin should be defined as no exposure of the tumor on the cut surface and no contiguity to a main branch.
We also observed a significant difference in Recent studies in Japan have found no significant differences in prognosis between synchronous and metachronous hepatectomy under certain conditions 9, 26 . These studies have recommend synchronous hepatectomy for four types of patients:
those with a adequate tumor-free hepatic margin, those requiring resection of only one hepatic section to remove the liver metastases, those 70 years or younger, and those without poorly differentiated or mucinous adenocarcinoma as the primary lesion.
Our policy is to resect hepatic lesions and the primary lesions at the same time whenever the lesions are found synchronously. Our study found no significant differences in overall survival between patients undergoing synchronous hepatectomy and those undergoing metachronous hepatectomy .
However, our study was not randomized and included to few patients in the analyses to support definitive conclusions. In light of advances in the techniques and instruments for hepatectomy, however, we will continue favoring synchronous hepatectomy at our institution.
Conclusion
No significant differences in the overall survival rates were found between patients with synchronous liver metastases from colorectal cancer and patients with metachronous liver metastases.
Patients with synchronous liver metastases from colorectal cancer should undergo radical resection of the primary lesion and simultaneous hepatectomy with an adequate tumor-free margin as a standard surgical course.
Hepatic lesions should be resected together with primary lesions when they are found synchronously.
